What Should be the Treatment Approach in Patients with Cardiac Allograft Vasculopathy?

dc.contributor.authorErsoy, Ozgur
dc.contributor.authorBeyazpinar, Sarp
dc.contributor.authorGultekin, Bahadir
dc.contributor.authorSezgin, Atilla
dc.contributor.authorAslamaci, Sait
dc.contributor.researcherIDABA-7388-2021en_US
dc.date.accessioned2023-05-18T11:14:00Z
dc.date.available2023-05-18T11:14:00Z
dc.date.issued2018
dc.identifier.endpageS830en_US
dc.identifier.issn0041-1337en_US
dc.identifier.issueSupplement 7en_US
dc.identifier.startpageS830en_US
dc.identifier.urihttp://hdl.handle.net/11727/9089
dc.identifier.volume102en_US
dc.identifier.wos000444541201602en_US
dc.language.isoengen_US
dc.relation.isversionof10.1097/01.tp.0000543881.63211.96en_US
dc.relation.journalTRANSPLANTATIONen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleWhat Should be the Treatment Approach in Patients with Cardiac Allograft Vasculopathy?en_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: